$115 Million is the total value of New England Research & Management, Inc.'s 168 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VRX | Exit | Valeant Pharma Int'lcs | $0 | – | -1,600 | -100.0% | -0.18% | – |
COST | Exit | Costco Wholesalecs | $0 | – | -1,865 | -100.0% | -0.19% | – |
RDSA | Exit | Royal Dutchcs | $0 | – | -3,000 | -100.0% | -0.22% | – |
GTLS | Exit | Chart Industries Inc.cs | $0 | – | -3,100 | -100.0% | -0.23% | – |
BAGL | Exit | Einstein Noah Restaurant Groupcs | $0 | – | -16,700 | -100.0% | -0.24% | – |
TRP | Exit | TransCanada Corpcs | $0 | – | -5,750 | -100.0% | -0.24% | – |
STLD | Exit | Steel Dynamicscs | $0 | – | -15,275 | -100.0% | -0.24% | – |
SPXC | Exit | SPX Corpcs | $0 | – | -2,600 | -100.0% | -0.25% | – |
GPS | Exit | The Gap Inc.cs | $0 | – | -7,825 | -100.0% | -0.29% | – |
WYND | Exit | Wyndham Worldwidecs | $0 | – | -4,436 | -100.0% | -0.30% | – |
PSMT | Exit | PriceSmart, Inc.cs | $0 | – | -4,075 | -100.0% | -0.32% | – |
EL | Exit | Estee Laudercs | $0 | – | -5,090 | -100.0% | -0.34% | – |
HD | Exit | Home Depotcs | $0 | – | -5,275 | -100.0% | -0.38% | – |
NTRS | Exit | Northern Trustcs | $0 | – | -7,500 | -100.0% | -0.43% | – |
VRSK | Exit | Verisk Analyticscs | $0 | – | -8,025 | -100.0% | -0.43% | – |
HSP | Exit | Hospiracs | $0 | – | -9,600 | -100.0% | -0.44% | – |
CLX | Exit | Clorox Companycs | $0 | – | -5,550 | -100.0% | -0.45% | – |
COF | Exit | Capital One Finl.cs | $0 | – | -6,800 | -100.0% | -0.50% | – |
SRCL | Exit | Stericycle, Inccs | $0 | – | -4,900 | -100.0% | -0.52% | – |
DRI | Exit | Darden Restaurantscs | $0 | – | -12,875 | -100.0% | -0.53% | – |
STX | Exit | Seagate Technology PCcs | $0 | – | -16,850 | -100.0% | -0.86% | – |
IHG | Exit | InterContinental Hotelscs | $0 | – | -41,525 | -100.0% | -1.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-10-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Church and Dwight | 40 | Q3 2023 | 5.1% |
Johnson & Johnson | 40 | Q3 2023 | 3.9% |
Cisco Systems | 40 | Q3 2023 | 3.4% |
Kimberly-Clark | 40 | Q3 2023 | 2.9% |
Apple Computer | 40 | Q3 2023 | 3.4% |
Exxon Mobil | 40 | Q3 2023 | 2.9% |
Pfizer | 40 | Q3 2023 | 2.3% |
Microsoft | 40 | Q3 2023 | 2.8% |
CSX Corp | 40 | Q3 2023 | 2.2% |
Merck | 40 | Q3 2023 | 1.9% |
View New England Research & Management, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-16 |
13F-HR | 2024-02-06 |
13F-HR | 2023-10-10 |
13F-HR | 2023-07-05 |
13F-HR | 2023-04-06 |
13F-HR | 2023-01-09 |
13F-HR | 2022-10-06 |
13F-HR | 2022-07-20 |
13F-HR | 2022-04-20 |
13F-HR | 2022-01-05 |
View New England Research & Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.